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Society. Interestingly, C.H. Li impressed renowned physical chemist Gilbert N. Lewis, inventor of Lewis structures and then Dean of UC Berkeley College of Chemistry, with this paper and received an acceptance to the graduate program.
Ranging from original photographs to pictures from university archives, the insightful curation of images in this book further enhances the reading experience. We get to see the elementary schools that they attended, the prestigious award ceremonies honoring them, and everything in between. The photos not only help us to grasp the historical, sociocultural, and geographical contexts of each laureate's journey, but they also make the narratives personal and relatable. Some of my favorite images include a photo of Pui Ying High School in Guangzhou where C.H. Li attended, patient data from M.C. Li's publications in the 1950s on choriocarcinoma treatment, Kan's graduation class at the University of Hong Kong in 1958, and the ancient medical texts that inspired Tu.
An authoritative and comprehensive synthesis of both primary and secondary sources, Nobel and Lasker Laureates of Chinese Descent offers unparalleled insight into the most eminent twentiethcentury physicians and scientists of Chinese descent. The book is of broad interest to anyone interested in the history of science and medicine, especially when there is a growing recognition of both the importance of diversity in STEM and the impact of Chinese research on the global scientifi c community. In an interview with South China Morning Post, Laurence K. Chan, one of the editors of the book, advocates for increased research spending in both China and Hong Kong to continue cultivating and nurturing the next generation of scientists.
The book aims to "motivate people throughout the world to excel in their studies so that they can give back to their communities and the world at large." As I begin my own physician-scientist training this summer, I take the experiences of the four Lasker laureates to heart. Their stories reinvigorate my own commitment to make a lasting impact on medicine and improve people's lives. Rich is also an amazing writer. I wish that I had saved some of my fi rst drafts with Rich's comments on them. He revised entire paragraphs using his red pen to fi t his teeny tiny corrections between my original lines. Alan Grossman, my postdoc advisor at MIT, taught me the importance of patience and the value of a positive mindset. In the face of experimental mishaps, Alan would remind us that, like in baseball, batting .300 at the bench is great. Many senior women in my fi eld also inspired me to chart my own course. They include Carol Gross, Lucy Shapiro, Lucia Rothman-Denes, Susan Gottesman, Gisela Storz, Bonnie Bassler, Susan Rosenberg, and Tania Baker. They all lead by example. They blazed different paths to success as scientists and mentors. Ursula Goodenough, now emerita in my department at Washington University, is another fantastic role model. Ursula is a fabulous scientist, mentor, and just all-around excellent individual. She also speaks her mind on social and moral issues. When I was worried about being a new mother on tenure track, Ursula encouraged me with her story: she raised fi ve children, breastfed them all, and had a great professional career. Hearing that gave me the confi dence to know that I could also be a good mother and scientist.
What is the best advice you've been given? You make your own luck! What's your favorite experiment? My favorite experiment is usually the latest one, especially if it involves imaging or clever genetics. Still better if it includes both.
What has been your biggest mistake?
Failing to advocate for myself enough. I am still working on that…
What is your favorite conference?
That's easy: the annual Molecular Genetics of Bacteria and Phages Meeting in Madison, Wisconsin, is my favorite. The best part is that most talks are selected from abstracts, giving everyonegraduate students, postdocs, PIs, and even undergraduates -a chance to present at a major conference. The second best part is that the meeting is held every August in the Wisconsin Memorial Union overlooking Lake Mendota. Having your meals and drinks on the Terrace right on the lake is the best environment for reconnecting with old friends and making new ones. Do you feel a push toward more applied science. How does that affect your own work? Yes. As a bacteriologist, I am scared that we could return to a 'pre-antibiotic' age. That isn't overdramatic. The challenge of antibiotic resistance among pathogens is growing. People are dying. Pharma companies are scaling back investments in nextgeneration antibiotics just as the current generation becomes less effective. That's why my group now is working on the issue. It started when I visited my dentist and noticed that the toothpaste sample I got in the 'goody bag' at the end of the appointment included triclosan as an antibacterial agent. That got me thinking whether such everyday antimicrobials hurt us more than help us. Our research shows that the answer is yes. We also tried to make our research story relevant. To our surprise, our fi ndings were picked up by some media outlets. It's a small contribution to public understanding of antibiotic resistance, but we are happy with it and plan to continue working in this area. Do you believe that there is a need for more crosstalk between biological disciplines? Absolutely! Attending a seminar outside of your fi eld is one of the best ways to stimulate new thinking. Our work on cell size has given me the opportunity to attend meetings focusing on size and scaling across biology. These meetings have introduced me to investigators who are working on topics as diverse as beetle horn evolution, fl agellar length, and organ size, as well as theoretical biologists and biophysicists. I always come away with new ideas and connections that I never would have had unless I took the time to step outside of my comfort zone.
Any strong views on social media and science? Science Twitter has been a revelation. I love it when investigators post a brief description and link to their latest preprint or publication. Having a little bit of the story behind the story -not to mention feeling someone's enthusiasm for their hard work -is 100 times better than sifting through dozens of e-mails with the latest table of contents. (No offense CB!) I also think that social media can help to encourage younger scholars, recognize their successes, and introduce them to our community.
Which aspect of science, your fi eld or in general, do you wish the general public knew more about? While it's gotten a bit better thanks to recent work on the microbiome, I think that most people either are scared of bacteria ('they are bad!') or fi nd them boring ('why aren't you studying something important like cancer?'). This is troubling. Bacteria are everywhere and fundamental to every aspect of life. By understanding bacteria, we better understand all life. And they are fun systems to study! Do you think that there is too much emphasis on big data-gathering collaborations as opposed to hypothesis-driven research by small groups? 'Big data' collaborations are making important contributions. Consider climate change research and the human microbiome project as two great examples. That said, I am a big believer in the idea (put forth eloquently by Bruce Alberts here https://bit.ly/222FXky (Cell (1985) 41, 337-338) and Jon Lorsch, Director of the National Institute of General Medical Sciences, here https:// bit.ly/2GQswRa) that small labs can be equally if not even more effi cient than large labs in doing good science. I've intentionally kept my group small (<6 fulltime people), and this way I can invest in every team member as both a scientist and a mentor. If my group were larger, I doubt I could give each team member the time and coaching that they deserve to reach their potential.
What do you think are the biggest problems science as a whole is facing today? Communication tops my list. Scientists often don't communicate in ways that connect with people outside of our specialties, and this has real-world consequences. We are all responsible here -from microbiologists to climate scientists. Too often, scientists conveyunwittingly perhaps -that, since we have expertise, people should just trust us. If people don't, we can get upset and even blame the audience. No one should be trusted just because they have a PhD after their name. I've been reading about the strategies that medical doctors are now using to convince parents who don't trust vaccines to vaccinate their children. The most effective approach appears pretty simple in concept but hard to do in practice: answer questions thoughtfully and respectfully, even if that takes much more time than the typical offi ce visit. In the same way, more scientists need to step up and fi nd ways in our classrooms, in our writing, in everyday conversations, and, yes, in public discussions to explain our work in ways that are meaningful to those outside of our subfi elds. I admit that this isn't something that comes naturally to me. But I like to think that engaging non-scientists is like giving a good talk to a scientifi c audience: be mindful of your audience, make them feel smart by treating them with respect, and tell a clear story. That can make a big difference in how our work is understood and perceived. It's not easy, but we need to do more of it. 
So what exactly are microtubules?
Microtubules are fi lamentous polymers of /-tubulin that perform a variety of functions in cells, such as separating chromosomes during mitosis and acting as tracks along which molecular cargo is transported. The /-tubulin dimers join head-to-tail to form linear protofi laments that associate laterally to form the tube-based structure of the microtubule. Microtubules typically contain 13 protofi laments, although this can vary. Due to the inherent asymmetry of /-tubulin dimers, microtubules are polarised, with -tubulin exposed at the so-called minus end and -tubulin exposed at the so-called plus end. This structural polarity has functional consequences: the plus end typically grows and shrinks faster and more often than the minus end and each end is recognised and bound by different proteins, such as EB1 at the plus end and CAMSAP/Patronin at the minus end. Moreover, different motor protein complexes move in a particular direction: dynein motors move towards the minus end, while most kinesin motors move towards the plus end. This is particularly important in polarised cells such as neurons, and in cilia/fl agella, where particular cargo needs to be moved in a specifi c direction. 
Quick guide
assembly defects and model organisms, such as Drosophila, are inviable. -TuRCs have multiple components: a core set of three proteins, -tubulin, GCP2 and GCP3, which are essential for -TuRC function; and additional components, such as GCP4-6, NEDD1/Grip71 and MZT1, which are usually dispensable for at least some microtubule nucleation events and may therefore have evolved to help control specifi c nucleation events. For example, Drosophila Grip71 is dispensable for nucleation at centrosomes but essential for microtubule nucleation from within the mitotic spindle.
How do -TuRCs promote microtubule nucleation? Purifi ed tubulin dimers can spontaneously polymerise into microtubules in vitro at high enough protein concentrations (> ~20 M), but at lower (likely more physiological) concentrations the addition of purifi ed -TuRCs increases the potential for microtubule nucleation. Seminal work in budding yeast has shown that -tubulin molecules within a -TuRC are held by GCP2 and GCP3 proteins in a singleturn helix conformation. The -tubulin molecules are thought to bind directly to incoming /-tubulin dimers and promote the weak lateral interactions between growing protofi laments. The helical arrangement of -tubulin molecules leads to what is known as the microtubule seam, where the fi rst and last protofi laments join.
How are -TuRCs made? In budding yeast, -TuRCs form when seven -tubulin small complexes (-TuSCs; containing two molecules of -tubulin and one each of GCP2 and GCP3) associate laterally to form a single-turn helix-like structure that has overlapping ends. This overlap explains why -TuRCs that are made from -TuSCs containing an even number of -tubulin molecules can generate microtubules with an odd number of protofi laments. Budding yeast -TuRCs form only at the spindle pole body, presumably because the assembly of -TuSCs into -TuRCs is driven by the binding of other non--TuRC proteins concentrated at this site, such as Spc110, Spc72 and Stu2. In higher eukaryotes, however, at least a fraction of -TuRCs are preformed in the cytosol before being recruited to MTOCs. This appears to be facilitated by some of the additional -TuRC components (GCP4-6
